ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 91.3% of REGN shares are held by financial institutions. DIMENSIONAL FUND ADVISORS LP is the top corporate investor, holding 588.95K shares valued at $566.86M. A 0.55% stake in Regeneron Pharmaceuticals, Inc. is owned by the company. CAPITAL WORLD INVESTORS owns 4.65M shares valued at $4.48B, which translates its holding of 4.32% of the stake in the company.
Among the REGN insiders holding of 1.58% of the stake in company, YANCOPOULOS GEORGE, Bd. Co-Chair, President & CSO, holds the largest shares of 786.38K. STAHL NEIL, EVP Research and Development, is the second largest REGN insider with ownership of 51K shares. MURPHY ANDREW J, EVP Research, stands third with possession of 48.31K shares of that stake.